3.18.02: Pharmaceutical Industry Issue
Five analysts, one expert and top management from twenty-three sector firms examine the pharmaceutical Industry sector in this special 111-page Pharmaceutical Industry issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Medical Technology & Devices Issue & Pharmacy Benefit Managers Report

  1. Pharmaceutical Industry - In an in-depth (14,300 words) Analyst Roundtable, Mario Corso, Vice President at Leerink Swann & Company, Adam Greene, Vice President at Dresdner Kleinwort Wasserstein, Mariola B. Haggar, President at Haggar Concord Partners, LP, Richard R. Stover, Global Pharmaceuticals Analyst at Arnhold and S. Bleichroeder, Inc., Peter Wen, Vice President at Credit Suisse Asset Management, examine the outlook for the sector including EPS growth, industry trends and share specific stock recommendations.
  2. Outlook for Pharmaceuticals & Life Sciences - In an in-depth (3,500 words) Expert Interview, John D. Rhodes, Managing Partner for Pharmaceuticals and Life Sciences at Deloitte & Touche, examines the outlook for the sector.
  3. The TWST confidential Off-The-Record survey of management performance of eleven sector firms asked market insiders about the ability of management teams to create shareholder value. Firms reviewed in Off-The-Record include:
    Andrx, Barr Laboratories, Bristol-Myers Squibb, Eli Lilly and Company, Merck & Co., Pfizer, Pharmaceutical Resources, Pharmacia, Schering-Plough, SICOR, Watson Pharmaceuticals
  4. CEO interviews (average 2,500 words). Top management of twenty-three sector firms examine the outlook for their firm and the sector. Firms include:
    Vernalis Group, Cell Pathways, Lifepoint Hospitals, aaipharma, AEterna Laboratories, Allou Health & Beauty Care, AmerisourceBergen, Astralis, Genzyme Transgenics, Hemispherx Biopharma, Integrated Surgical Systems, MedMira, Milestone Scientific, MIV Therapeutics, Novoste, Ostex International, Paladin Labs, Sonus Pharmaceuticals, Spectral Diagnostics, SpectRx, STAAR Surgical, Trinity Biotech, Vital Signs
    5. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE